PB1935: CARDIOTOXICITY AND SAFETY OF BRUTON’S TYROSINE KINASE INHIBITORS: A REVIEW OF REAL-WORLD OBSERVATIONAL EVIDENCE
Main Authors: | Chakrapani Balijepalli, Gaye Siliman, Juhi Joshy, Lakshmi Gullapalli, Eric Druyts |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000974560.08770.66 |
Similar Items
-
Bruton’s Tyrosine Kinase Inhibitors: Recent Updates
by: Amneh Fares, et al.
Published: (2024-02-01) -
The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
by: Obada Ababneh, et al.
Published: (2022-05-01) -
The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
by: Abdullah Mohammad Khan
Published: (2022-04-01) -
A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis
by: Laura Airas, et al.
Published: (2024-04-01) -
Expression of Bruton's tyrosine kinase in osteoclasts
by: Danks, L, et al.
Published: (2005)